Maven Securities »

Rapport Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $594k 20k 29.70
2024-09-30 $613k 30k 20.48

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Ark Etf Tr Call Call Option
Newmont Corp Put Put Option
Nvidia Corporation Call Call Option
Eli Lilly & Co Put Put Option
Fedex Corp Call Call Option
Tesla Motors (TSLA)
Select Sector Spdr Tr Financial (XLF)

View all positions for Maven Securities

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics